Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-012970
Filing Date
2024-02-08
Accepted
2024-02-08 19:25:32
Documents
2
Period of Report
2024-02-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1584
2 EX-24 mgx-ex24.htm EX-24 12379
  Complete submission text file 0000950170-24-012970.txt   15524
Mailing Address TWO CORPORATE DRIVE C/O FIVE PRIME THERAPEUTICS, INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Borges Luis (Reporting) CIK: 0001684015 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41949 | Film No.: 24610775

Mailing Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608
Business Address 5959 HORTON STREET 7TH FLOOR EMERYVILLE CA 94608 (510) 871-4880
Metagenomi, Inc. (Issuer) CIK: 0001785279 (see all company filings)

EIN.: 813909017 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)